Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorZhuang Hongqing
About this trial
This study aims to assess multimodal Radiomics-based prediction model for prognostic prediction in spinal tumors.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- No interventions
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Zhuang Hongqing
Lead sponsor
Peking University Third Hospital
Sponsor institution
Source ClinicalTrials.gov